We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.50
Bid: 51.00
Ask: 54.00
Change: 0.00 (0.00%)
Spread: 3.00 (5.882%)
Open: 52.50
High: 52.50
Low: 52.50
Prev. Close: 52.50
BVT Live PriceLast checked at -
Baronsmead Venture Trust is an Investment Trust

To achieve long-term investment returns for private investors by investing primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

24 May 2017 07:00

RNS Number : 0287G
Baronsmead Venture Trust PLC
24 May 2017
 

Baronsmead Venture Trust plc

Half-Yearly report for the six months ended

31 March 2017

 

The Directors announce the unaudited half-yearly financial report for the six months to 31 March 2017.

 

Copies of the half-yearly report can be obtained from the following website: www.baronsmeadvcts.co.uk.

 

Our Investment Objective

 

Baronsmead Venture Trust is a tax efficient listed company which aims to achieve long-term investment returns for private investors, including tax free dividends.

 

Investment Policy

 

· To invest primarily in a diverse portfolio of UK growth businesses, whether unquoted or traded on AIM.

· Investments are made selectively across a range of sectors in companies that have the potential to grow and enhance their value.

 

Dividend Policy

 

The Board of Baronsmead Venture Trust aims to sustain a minimum annual dividend level at an average of 6.5p per ordinary share, mindful of the need to maintain net asset value. The ability to meet these twin objectives depends significantly on the level and timing of profitable realisations and cannot be guaranteed. There will be variations in the amount of dividends paid year on year.

 

Shareholder choice

 

The Board wishes to provide shareholders with a number of choices that enable them to utilise their investment in Baronsmead Venture Trust in ways that best suit their personal investment and tax planning requirements and in a way that treats all shareholders equally.

 

· Fund raising | From time to time the Company seeks to raise additional funds by issuing new shares at a premium to the latest published net asset value to account for issue costs. This enables shareholders seeking additional investments to do so with taxation relief.

 

· Dividend Reinvestment Plan | The Company offers a Dividend Reinvestment Plan which enables shareholders to purchase additional shares through the market in lieu of cash dividends. Approximately 638,000 shares were bought in this way during the six months to 31 March 2017.

 

· Buy back of shares | From time to time the Company buys its own shares through the market in accordance with its share price discount policy. Subject to certain conditions, the Company seeks to maintain a mid market share price discount of approximately 5 per cent. to net asset value.

 

· Secondary market | The Company's shares are listed on the London Stock Exchange and can be bought or sold by shareholders using a stockbroker or authorised share dealing service in the same way as shares of any other listed company. Approximately 2,980,000 shares were bought by investors in the Company's existing shares in the six months to 31 March 2017.

 

Financial Headlines

 

· + 4.8% - Net asset value ("NAV") per share increased 4.8 per cent. to 91.23p in the six months to 31 March 2017, before deduction of dividends.

 

· 380.6p - NAV total return to shareholders for every 100.0p invested at launch.

 

· 3.0p - Dividends totalled 3.0p in the six month period ended 31 March 2017.

 

 

Cash returned to shareholders by date of investment 

 

The table below shows the cash returned to shareholders that invested in Baronsmead Venture Trust plc (formerly known as Baronsmead VCT 2 plc) dependent on their subscription cost, including the income tax available to be reclaimed on the subscription.

 

Year subscribed

Cash invested

 (p)

Income tax reclaim

(p)

 

Net cash invested

(p)

Cumulative dividends

paid

 (p)

Return on cash invested (%)

1998 (April)

100.0

20.0

80.0

143.4

163.4

1999 (May)

102.0

20.4

81.6

139.9

157.2

2000 (February)

137.0

27.4

109.6

136.7

119.8

2000 (March)

130.0

26.0

104.0

136.7

125.2

2004 (October) - C*

100.0

40.0

60.0

93.2

133.2

2009 (April)

91.6

27.5

64.1

75.5

112.4

2012 (December)

111.8

33.5

78.3

50.0

74.7

2014 (March)

103.8

31.1

72.7

32.5

61.3

2016 (February)

102.8

30.8

72.0

18.0

47.5

 

* Share dividend calculated using conversion ratio of 0.9657, which is the rate the C shares were converted into ordinary shares.

 

 

Chairman's Statement 

 

I am pleased to report a 4.8 per cent. (4.1p) increase in NAV per share for the six months to 31 March 2017 before dividend payments. An interim dividend of 3.0p per share was paid on 31 March 2017 in lieu of the dividend that would have otherwise been paid in June 2017 following the publication of these results.

 

Results

During the six months to 31 March 2017, the Company's NAV per share increased 4.8 per cent. from 87.1p to 91.2p before dividends.

 

 

Pence per ordinaryshare

NAV as at 1 October 2016

87.1

Valuation uplift (4.8 per cent.)

4.1

NAV as at 31 March 2017 before dividends

91.2

Less:

 

Interim dividend paid to the shareholders on 31 March 2017

 

 

 

(3.0)

NAV as at 31 March 2017 after dividends

88.2

 

The increase in NAV of 4.8 per cent. was the result of steady progress across our investment portfolio. Over the six months to 31 March 2017, our unquoted investments delivered an increase in their valuations of 3.0 per cent. Despite the continued volatility of the quoted markets, the value of our AIM-traded investments increased by 8.1 per cent. and our investment in CF Livingbridge UK Micro Cap Fund ("Micro Cap Fund", previously Wood Street Microcap Investment Fund) increased by 9.2 per cent.

 

Portfolio Review

 

At 31 March 2017, the Company's investment portfolio was valued at £118m and comprised investments in 73 unquoted and AIM-traded companies. In addition, the Company's investment in the Micro Cap Fund provides investment exposure to a further £20m in 44 AIM-traded and fully listed companies.

 

Investment and Divestments

 

The Company's investments and divestments during the period are set out in the tables below.

 

The new VCT rules introduced in November 2015 have required the Investment Manager to adapt its investment strategy to focus on the provision of development capital to younger companies to enable them to grow their businesses organically rather than through acquisition. This transition has taken time to achieve as the Manager has had to consider how best to deploy funds in generally, earlier stage companies whilst maintaining its investment quality standards and this has resulted in fewer new investments than in prior years. The Board has been supportive of a cautious approach during this transition as a hasty or imprudent deployment of funds could have proved expensive in terms of a loss of capital and a reduction in the long-term return to shareholders.

 

I am now pleased to report that either side of the period end the Company made two new unquoted investments as well as three investments in AIM-traded companies for a total investment of £1.9m during the period under review and £2.7m subsequently. The Board is also encouraged to note that the pipeline of potential new investments is improving and anticipates the investment of further funds over the course of the Summer.

 

Dividends

 

An interim dividend of 3.0p per share was paid on 31 March 2017 in lieu of the dividend that would otherwise have been paid in June 2017, following the publication of the Company's results for the six months to 31 March 2017. The Board aims to sustain a minimum annual dividend level at an average of 6.5p per ordinary share and therefore in the ordinary course of events, would expect to declare a further final dividend for the financial year to 30 September 2017 which would be paid following shareholder approval at the Company's next AGM. The timing and level of future dividends depends significantly on the level and timing of profitable realisations and rate of investment. Inevitably, as these cannot be guaranteed, there will be variations in the amounts and dates that dividends are paid.

 

Fundraising

 

The Board will be considering whether to raise new funds in the 2017/18 tax year which will be determined by the Company's cashflow and its anticipated requirements to fund new investments over the next two years. The Board appreciates that shareholders would like as much notice as possible of its fundraising intentions so that they can plan their financial affairs accordingly. Ordinarily, the Board would seek to raise funds during January and February, having informed shareholders of its fundraising intentions in November when its annual results are published. However, if it becomes appropriate to raise new funds earlier, the Board will ensure that shareholders are informed as soon as possible.

 

VCT Legislation and Policy Review

 

Legislative changes to VCTs included in the March 2017 Budget were limited to technical changes to the rules concerning the restructuring of investments. In addition, the Government's venture capital schemes (SEIS, EIS and VCTs) will be included in the recently announced Patient Capital Review which aims "to ensure that high growth businesses can access the long-term capital that they need to fund productivity enhancing investment". This will provide the VCT industry with the opportunity to demonstrate that the existing tax reliefs encourage investment and entrepreneurship and are effective, well targeted and provide excellent value for money for UK taxpayers. The Manager and Board will be fully engaged throughout this process, with a view to informing you of the conclusions of the Review and any policy recommendations that might be brought forward.

 

Outlook

 

Despite signs of a slowdown in the wider economy, as the impact of a much-weakened sterling finally begins to work its way through to the consumer, there are no signs yet of a deterioration in performance in the Company's portfolio.

 

The outlook for the rest of 2017 remains uncertain, with the potential for macro and geopolitical events to impact sentiment and create market volatility. However, the Manager continues to focus on areas of sectoral growth and companies that have the potential to grow profits even without a tailwind from the wider economy.

 

This is reflected in the valuation of the Company's investments in the NAV at 30 April 2017 which has grown by a further 1.6p per share, to 89.8p per share. Whilst changes in market sentiment may impact the valuation of investments in the short term and the general election may result in a slowdown of business transactions over the coming weeks, the diversity and quality of the Company's portfolio should continue to deliver consistent returns for shareholders over the medium to long term.

 

Peter Lawrence

Chairman

24 May 2017

 

 

 

Investment Diversification at 31 March 2017

 

 

Sector by value

 

Percentage

 

 

Business Services

31%

Consumer Markets

17%

Healthcare & Education

13%

Technology, Media & Telecommunications ("TMT")

39%

 

 

Total assets by value

 

Percentage

 

 

Unquoted - loan stock

25%

Unquoted - equity

8%

AIM

44%

Collective investment vehicles

21%

Net current assets (principally cash)

2%

 

 

Time investments held by value

 

Percentage

 

 

Less than 1 year

2%

Between 1 and 3 years

24%

Between 3 and 5 years

35%

Greater than 5 years

39%

Investments in the period

Company

Location

Sector

Activity

Book cost

£'000

Unquoted investments

New

Custom Materials Ltd

London

Consumer Markets

Retailer of customisable products

225

Total unquoted investments

225

AIM-traded investments

New

FreeAgent Holdings plc

Edinburgh

TMT*

Online accounting software

788

Collagen Solutions plc

London

Healthcare &

Education

 

Develops and manufactures medical grade collagen

337

Follow on

 

 

 

 

CloudCall Group plc

Leicestershire

TMT*

Cloud based telephony platform

599

Total AIM-traded investments

1,724

Total investments in the period

1,949

 

* Technology, Media & Telecommunications ("TMT").

 

Realisations in the period

 

Company

 

 

First

investment

date

Proceeds

£'000

Overall

multiple

return

Unquoted realisations

CR7 Services Ltd

 

Part trade sale

Aug 14

11

0.0

Total unquoted realisations

 

 

 

11

 

AIM-traded realisations

Ubisense Group plc

 

Part market sale

Jun 11

22

0.3

Total AIM-traded realisations

 

 

 

22

 

Total realisations in the period

 

 

 

33

 

Deferred consideration of £60,000 was received in respect of Kingsbridge Risk Solutions, which had been sold in a prior period.

 

 

Independent Review Report to Baronsmead Venture Trust plc

 

Introduction

 

We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 31 March 2017 which comprises the Condensed Income Statement, Condensed Balance Sheet, Condensed Statement of Changes in Equity, Condensed Statement of Cash Flows and the related explanatory notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.

 

 

This report is made solely to the Company in accordance with the terms of our engagement to assist the Company in meeting the requirements of the Disclosure Guidance and Transparency Rules ("the DTR") of the UK's Financial Conduct Authority ("the UK FCA"). Our review has been undertaken so that we might state to the Company those matters we are required to state to it in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company for our review work, for this report, or for the conclusions we have reached.

 

 

Directors' responsibilities

 

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the DTR of the UK FCA.

 

As disclosed in note 1, the annual financial statements of the Company are prepared in accordance with UK Accounting Standards and applicable law (UK Generally Accepted Accounting Practice), including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with FRS 104 Interim Financial Reporting.

 

 

Our responsibility

 

Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly financial report based on our review.

 

Scope of review

 

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 Review of Interim Financial Information Performed by the Independent Auditor of the Entity issued by the Auditing Practices Board for use in the UK. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

 

Conclusion

 

Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 31 March 2017 is not prepared, in all material respects, in accordance with FRS 104 Interim Financial Reporting and the DTR of the UK FCA.

 

John Waterson

for and on behalf of KPMG LLP

Chartered Accountants

Saltire Court

20 Castle Terrace

Edinburgh EH1 2EG

24 May 2017

 

 

Responsibility Statement of the Directors in respect of the Half-Yearly Financial Report

 

We confirm that to the best of our knowledge:

● the condensed set of financial statements has been prepared in accordance with FRS 104 Interim Financial Reporting

● the interim management report includes a fair review of the information required by:

 

a) DTR 4.2.7R of the Disclosure Guidance and Transparency Rules, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements; and a description of the principal risks and uncertainties for the remaining six months of the year; and

 

b) DTR 4.2.8R of the Disclosure Guidance and Transparency Rules, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the entity during that period; and any changes in the related party transactions described in the last annual report that could do so.

 

On behalf of the Board,

 

Peter Lawrence

Chairman

24 May 2017

 

Condensed Income Statement

For the six months to 31 March 2017

 

 

 

Six months to31 March 2017

Six months to31 March 2016

Year to30 September 2016

 

Notes

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

 

Capital

£'000

 

Total

£'000

 

Revenue

£'000

 

Capital

£'000

 

Total

£'000

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealised gains on movement in fair value of investments

7

-

8,161

8,161

-

 

3,870

 

3,870

 

-

 

3,190

 

3,190

Realised gains on disposal of investments

7

-

64

64

-

 

1,438‌‌‌‌

 

1,438‌‌‌‌

 

-

 

2,931

 

2,931

Income

 

1,037

-

1,037

1,140

 

-

 

1,140

 

2,115

 

-

 

2,115

Investment management fee

 

(370)

(1,370)

(1,740)

(277)

 

(938)

 

(1,215)

 

(650)

 

(1,949)

 

(2,599)

Other expenses

 

(284)

-

(284)

(712)

 

-

 

(712)

 

(990)

 

-

 

(990)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit on ordinary activities before taxation

 

383

6,855

7,238

151

 

4,370‌‌‌‌

 

4,521

 

475

 

4,172

 

4,647

Taxation on ordinary activities

 

-

-

-

-

 

-

 

-

 

-

 

-

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Profit for the period, being total comprehensive income for the period

 

383

6,855

7,238

151

 

4,370

 

4,521

 

475

 

4,172

 

4,647

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Return per ordinary share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic and Diluted

 

2

0.22p

3.96p

4.18p

0.14p

 

4.02p

 

4.16p

 

 

0.34p

 

 

2.98p

 

 

3.32p

 

All items in the above statement derive from continuing operations.

 

There are no recognised gains and losses other than those disclosed in the Income Statement.

 

The revenue column of the Income Statement includes all income and expenses. The capital column accounts for the realised and unrealised profit or loss on investments and the proportion of the management fee charged to capital.

 

The total column of this statement is the Statement of Total Comprehensive Income of the Company prepared in accordance with the Financial Reporting Standard ("FRS"). The supplementary revenue return and capital return columns are prepared in accordance with the Statement of Recommended Practice issued in November 2014 and updated in January 2017 by the Association of Investment Companies ("AIC SORP").

 

 

Condensed Statement of Changes in Equity

 

For the six months to 31 March 2017

 

 

 

 

Non-distributable reserves

Distributable reserves

Total

£'000

Notes

Called-up share capital

£'000

Share

premium £'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

At 1 October 2016

 

18,412

96,515

25,238

10,089

304

150,558

Profit/(loss) on ordinary activities after taxation

 

-

-

8,196

(1,341)

383

7,238

Net proceeds of share issue &

buybacks

4

-

-

-

1,033

-

1,033

Dividends paid

6

-

-

-

(4,862)

(347)

(5,209)

At 31 March 2017

 

18,412

96,515

33,434

4,919

340

153,620

 

 

For the six months to 31 March 2016

 

 

Non-distributable reserves

Distributable reserves

Total

£'000

Notes

Called-up share capital

£'000

Share premium £'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

At 1 October 2015

 

9,497

16,561

24,820

34,152

102

85,132

Profit on ordinary activities after taxation

 

-

-

734

3,636

151

4,521

Shares issued following the

acquisition of Baronsmead VCT plc

 

7,942

71,227

-

-

-

79,169

Net proceeds of share issue &

buybacks

 

973

8,727

-

(1,683)

-

8,017

Dividends paid

6

-

-

-

(2,905)

-

(2,905)

At 31 March 2016

 

18,412

96,515

25,554

33,200

253

173,934

 

 

For the year to 30 September 2016

 

 

Non-distributable reserves

Distributable reserves

Total

£'000

Notes

Called-up share capital

£'000

Share

premium £'000

Revaluation

reserve

£'000

Capital

reserve £'000

Revenue

reserve

£'000

At 1 October 2015

 

9,497

16,561

24,820

34,152

102

85,132

Profit on ordinary activities after taxation

 

-

-

418

3,754

475

4,647

Shares issued following the

acquisition of Baronsmead VCT plc

 

7,942

71,227

-

-

-

79,169

Net proceeds of share issues, share buybacks & sale of shares from treasury

 

973

8,727

-

422

-

10,122

Dividends paid

6

-

-

-

(28,239)

(273)

(28,512)

At 30 September 2016

 

18,412

96,515

25,238

10,089

304

150,558

 

 

Condensed Balance Sheet

As at 31 March 2017

 

 

Notes

 

As at

31 March

2017

£'000

As at 31 March 2016

£'000

As at30 September 2016

£'000

 

 

 

 

 

Fixed assets

 

 

 

 

Unquoted investments

7

50,908

53,182

49,286

Traded on AIM

7

67,342

62,555

60,575

Collective investment vehicles

7

32,092

17,748

18,400

Listed interest bearing securities

 

-

20,985

-

 

 

 

 

 

Investments

7

150,342

154,470

128,261

 

 

 

 

 

Current assets

 

 

 

 

Debtors

 

174

490

1,770

Cash at bank and on deposit

 

4,329

32,391

21,591

 

 

 

 

 

 

 

4,503

32,881

23,361

 

 

 

 

 

Creditors (amounts falling due within one year)

 

(1,225)

(13,417)‌‌‌‌

(1,064)

 

 

 

 

 

Net current assets

 

3,278

19,464

22,297

 

 

 

 

 

Net assets

 

153,620

173,934

150,558

 

 

 

 

 

Capital and reserves

 

 

 

 

Called-up share capital

 

18,412

18,412

18,412

Share premium

 

96,515

96,515

96,515

Capital reserve

 

4,919

33,200

10,089

Revaluation reserve

7

33,434

25,554

25,238

Revenue reserve

 

340

253

304

 

 

 

 

 

Equity shareholders' funds

 

153,620

173,934

150,558

 

 

 

 

 

 

 

 

 

As at

31 March

2017

£'000

 

As at 31 March 2016

£'000

 

As at30 September 2016

£'000

 

 

 

 

 

 

 

 

Net asset value per share

88.23

p

102.09

p

87.09

p

Number of ordinary shares in circulation

174,120,866

 

170,380,866

 

172,870,866

 

 

 

 

 

 

 

Treasury net asset value per share

88.00

p

101.49

p

86.80

p

Number of ordinary shares held in treasury

10,003,819

 

13,743,819

 

11,253,819

 

Number of listed ordinary shares in issue

184,124,685

 

184,124,685

 

184,124,685

 

Condensed Statement of Cash Flows

For the six months to 31 March 2017

 

 

Sixmonths to31 March 2017

£'000

Sixmonths to31 March2016

£'000

Year

to30 September 2016

£'000

 

 

 

 

Net cash outflow from operating activities

(798)

(655)

(1,518)

Net cash (outflow)/ inflow from investing activities

(13,856)

864

15,998

Equity dividends paid

(5,209)

(2,905)

(28,512)

 

 

 

 

Net cash outflow before financing activities

(19,863)

(2,696)

(14,032)

Net cash inflow from financing activities

2,601

24,380

24,916

 

 

 

 

(Decrease)/increase in cash

(17,262)

21,684‌‌‌‌

10,884

 

 

 

 

Reconciliation of net cash flow to movement in net cash

 

 

 

(Decrease)/increase in cash

(17,262)

21,684‌‌‌‌

10,884

Opening cash position

21,591

10,707

10,707

 

 

 

 

Closing cash at bank and on deposit

4,329

32,391

21,591

 

 

 

 

Reconciliation of profit on ordinary activities before taxation to net cash outflow from operating activities

 

 

 

Profit on ordinary activities before taxation

7,238

4,521

4,647

Gains on investments

(8,225)

(5,308)‌‌‌‌

(6,121)

Changes in working capital and other non-cash items

189

132‌‌‌‌

(44)

 

 

 

 

Net cash outflow from operating activities

(798)

(655)

(1,518)

 

 

 

 

 

Notes

1. The condensed financial statements for the six months to 31 March 2017 comprise the statements set out above together with the related notes below. The Company applies FRS 102 and the AIC's Statement of Recommended Practice issued in November 2014 and updated in January 2017 ('the SORP') for its annual financial statements. The condensed financial statements for the six months to 31 March 2017 have therefore been prepared in accordance with FRS 104 'Interim Financial Reporting' and the principles of the SORP. The accounts have been prepared on the same basis as the accounting policies set out in the Company's Annual Report and Financial Statements for the year ended 30 September 2016.

 

2. Return per share is based on a weighted average of 173,351,635 ordinary shares in issue (31 March 2016 - 108,808,998 ordinary shares; 30 September 2016 - 139,821,872 ordinary shares).

 

3. Earnings for the first six months to 31 March 2017 should not be taken as a guide to the results of the full financial year to 30 September 2017.

 

4. During the six months to 31 March 2017 the Company sold 1,250,000 shares out of treasury. At 31 March 2017, the Company held 10,003,819 ordinary shares in treasury. Shares may be sold out of treasury below Net Asset Value as long as the discount at issue is narrower than the average discount at which the shares were bought into treasury.

 

5. Excluding treasury shares, there were 174,120,866 ordinary shares in issue at 31 March 2017 (31 March 2016 - 170,380,866 ordinary shares; 30 September 2016 - 172,870,866 ordinary shares).

 

6. The interim dividend of 3.00p per share (2.80p capital, 0.20p revenue) was paid on 31 March 2017 to shareholders on the register on 10 March 2017. The ex-dividend date was 9 March 2017.

 

During the year to 30 September 2016, the Company paid a first interim dividend on 18 December 2015 of 3.50p per share (3.50p capital, nil revenue), a second interim dividend on 3 June 2016 of 6.50p per share (6.45p capital, 0.05p revenue) and a third interim dividend on 30 September 2016 of 8.50p per share (8.39p capital, 0.11p revenue).

 

7. All investments are initially recognised and subsequently measured at fair value. Changes in fair value are recognised in the Income Statement.

 

The methods of fair value measurement are classified into a hierarchy based on reliability of the information used to determine the valuation.

 

• Level 1 - Fair value is measured based on quoted prices in an active market.

• Level 2 - Fair value is measured based on directly observable current market prices or indirectly being derived from market prices.

• Level 3 - Fair value is measured using a valuation technique that is not based on data from an observable market.

 

 

Level 1

Level 2

Level 3

 

 

Traded

on AIM

£'000

Collective

investment

vehicles

£'000

Unquoted

£'000

Total

£'000

Opening book cost

50,409

12,451

40,163

103,023

Opening unrealised appreciation

10,166

5,949

9,123

25,238

Opening valuation

60,575

18,400

49,286

128,261

Movements in the period:

 

 

 

 

Purchases at cost

1,724

12,000

225

13,949

Sale - proceeds

(22)

-

(71)

(93)

- realised gains on sales

3

-

61

64

Unrealised losses realised during the period

(34)

-

(1)

(35)

Increase in unrealised appreciation

5,096

1,692

1,408

8,196

Closing valuation

67,342

32,092

50,908

150,342

Closing book cost

52,080

24,451

40,377

116,908

Closing unrealised appreciation

15,262

7,641

10,531

33,434

Closing valuation

67,342

32,092

50,908

150,342

Equity shares

67,342

-

12,952

80,294

Loan notes

-

-

37,956

37,956

Collective investment vehicles

-

32,092

-

32,092

Closing valuation

67,342

32,092

50,908

150,342

 

There has been no significant change in the risk analysis as disclosed in the Company's Annual Report and Accounts to 30 September 2016.

 

8. The financial information contained in this half-yearly financial report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The information for the year to 30 September 2016 has been extracted from the latest published audited financial statements. The audited financial statements for the year to 30 September 2016, which were unqualified, have been filed with the Registrar of Companies. No statutory accounts in respect of any period after 30 September 2016 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

 

9. The Company has one reportable segment being investing in primarily a portfolio of UK growth businesses, whether unquoted or traded on AIM.

 

10. Copies of the half-yearly financial report have been made available to shareholders and are available from the Registered Office of the Company at 100 Wood Street, London EC2V 7AN.

 

Principal Risks and Uncertainties

 

The Company's assets consist of equity and fixed interest investments, shares in collective investment schemes, cash and liquid resources. Its principal risks are therefore market risk, credit risk and liquidity risk. Other risks faced by the Company include loss of approval as a Venture Capital Trust, legislative, investment performance, economic, political and other external factors, regulatory and compliance and operational risks. These risks, and the way in which they are managed, are described in more detail in the Principal Risks & Uncertainties table within the Strategic Report section in the Company's Report and Accounts for the year to

30 September 2016. The Company's principal risks and uncertainties have not changed materially since the date of that report.

 

Related Parties

 

Livingbridge VC LLP ('the Manager') manages the investments of the Company. The Manager also provides or procures the provision of secretarial, administrative and custodian services to the Company. Under the management agreement, the Manager receives a fee of 2.0 per cent. per annum of the net assets of the Company. This is described in more detail under the heading 'The Investment Management Agreement' within the Strategic Report in the Company's Annual Report and Accounts for the year to 30 September 2016. During the period the Company has incurred management fees of £1,480,000 (31 March 2016 - £1,108,000; 30 September 2016 - £2,599,000) and secretarial fees of £72,000 (31 March 2016 - £75,000; 30 September 2016 - £147,000) payable to the Manager. A performance fee of £260,000 (31 March 2016 - £107,000; 30 September 2016 - £nil) has been accrued at 31 March 2017. This is described in more detail under the heading 'Performance fees' within the Strategic Report in the Company's Annual Report and Accounts for the year to 30 September 2016.

 

Going Concern

 

After making enquiries, and bearing in mind the nature of the Company's business and assets, the Directors consider that the Company has adequate resources to continue in operational existence for the foreseeable future. In arriving at this conclusion the Directors have considered the liquidity of the Company and its ability to meet obligations as they fall due for a period of at least twelve months from the date that these financial statements were approved. As at 31 March 2017 the Company held cash and readily realisable securities totalling £16,329,000 including £12,000,000 in JPMorgan Sterling Liquidity Fund. Cash flow projections have been reviewed and show that the Company has sufficient funds to meet both its contracted expenditure and its discretionary cash outflows in the form of the share buyback programme and dividend policy. The Company has no external loan finance in place and therefore is not exposed to any gearing covenants. 

 

Corporate Information

 

Directors

Peter Lawrence (Chairman)

Valerie Marshall

Les Gabb

Christina McComb

 

Secretary

Livingbridge VC LLP

 

Registered Office

100 Wood Street

London EC2V 7AN

 

Investment Manager

Livingbridge VC LLP

100 Wood Street

London EC2V 7AN

020 7506 5717

 

Registered Number

03504214

 

Registrars and Transfer Office

Computershare Investor Services PLC

The Pavilions

Bridgwater Road

Bristol BS99 6ZZ

Tel: 0800 923 1533

 

Brokers

Panmure Gordon & Co

One New Change

London EC4M 9AF

Tel: 020 7886 2500

 

Auditors

KPMG LLP

Saltire Court

20 Castle Terrace

Edinburgh EH1 2EG

 

Solicitors

Dickson Minto W.S.

Broadgate Tower

20 Primrose Street

London EC2A 2EW

 

VCT Status Adviser

PricewaterhouseCoopers LLP

1 Embankment Place

London WC2N 6RH

 

Website

www.baronsmeadvcts.co.uk

 

 

 

National Storage Mechanism

 

A copy of the Half-Yearly Report will be submitted shortly to the National Storage Mechanism ("NSM") and will be available for inspection at the NSM, which is situated at: www.morningstar.co.uk/uk/NSM.

 

 

END

 

 

Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on this announcement (or any other website) is incorporated into, or forms part of, this announcement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFSRESIVFID
Date   Source Headline
29th Apr 20243:30 pmRNSNet Asset Value(s)
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 202411:00 amRNSShare Allotment,Total Voting Rights,Close of Offer
19th Mar 20245:37 pmRNSClose of Offer to New Applications
18th Mar 20244:46 pmRNSDirector/PDMR Shareholding
15th Mar 20244:04 pmRNSTransaction in Own Shares
6th Mar 20243:00 pmRNSNet Asset Value(s)
6th Mar 20241:22 pmRNSResult of AGM
1st Mar 202410:20 amRNSTotal Voting Rights
15th Feb 20242:05 pmRNSDirector/PDMR Shareholding
15th Feb 20242:00 pmRNSAllotment of Shares and Total Voting Rights
7th Feb 202410:00 amRNSNet Asset Value(s)
2nd Feb 20248:00 amRNSIntention to Utilise Over-allotment Facility
1st Feb 20245:18 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNSTransaction in Own Shares
30th Jan 202412:01 pmRNSDirector/PDMR Shareholding
30th Jan 202412:00 pmRNSDirector/PDMR Shareholding
26th Jan 20242:30 pmRNSAllotment of Shares and Total Voting Rights
24th Jan 20245:00 pmRNSNet Asset Value(s)
24th Jan 20244:00 pmRNSNet Asset Value(s)
22nd Jan 20243:00 pmRNSOffer Update Extension of Early Bird Discount Date
19th Jan 20242:35 pmRNSIssue of Supplementary Prospectus
5th Jan 202411:36 amRNSChange of allotment date - correction
4th Jan 20243:45 pmRNSChange of allotment date
2nd Jan 202411:00 amRNSTotal Voting Rights
22nd Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20235:40 pmRNSTransaction in Own Shares
6th Dec 20231:30 pmRNSNet Asset Value(s)
24th Nov 20231:27 pmRNSPublication of a Prospectus/Offer for Subscription
22nd Nov 20237:00 amRNSCompliance with Market Abuse Regulation ("MAR")
14th Nov 202310:01 amRNSUpdate on Offer for Subscription
6th Nov 20234:01 pmRNSNet Asset Value(s)
27th Oct 20231:30 pmRNSNet Asset Value(s)
19th Oct 20234:51 pmRNSDirectorate Change
12th Oct 202311:22 amRNSAppointment of Non-Executive Director
2nd Oct 20234:00 pmRNSTotal Voting Rights
28th Sep 20235:52 pmRNSTransaction in Own Shares
12th Sep 20236:28 pmRNSTransaction in Own Shares - Replacement
12th Sep 20235:20 pmRNSTransaction in Own Shares
5th Sep 202311:00 amRNSIntention to Fundraise
4th Aug 20234:00 pmRNSNet Asset Value(s)
1st Aug 20231:52 pmRNSTotal Voting Rights
27th Jul 20234:11 pmRNSTransaction in Own Shares
24th Jul 20232:00 pmRNSNet Asset Value(s)
3rd Jul 202311:26 amRNSTotal Voting Rights
20th Jun 20233:45 pmRNSTransaction in Own Shares
13th Jun 20237:00 amRNSHalf-yearly Report
6th Jun 20235:30 pmRNSNet Asset Value(s)
12th May 20237:00 amRNSCompliance with the Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.